Johnson & Johnson ordered to pay $750m for deliberately concealing cancer-causing asbestos in its baby powder
Four plaintiffs with mesothelioma first accused Johnson & Johnson of covering up the fact its Baby Powder talc…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Feb 20
Four plaintiffs with mesothelioma first accused Johnson & Johnson of covering up the fact its Baby Powder talc…
10 Feb 20
In the Phase 1 clinical trial, OTX-TIC reduced intraocular pressure (IOP) in primary open angle glaucoma or ocular…
Azafaros works in rare disease treatment, developing small-molecule drugs — commonly known as pills — to reduce the…
Exscientia CEO Andrew Hopkins believes the majority of drug discovery will be done using a combination of AI…
06 Feb 20
The Phase 3 study evaluated RINVOQ for active psoriatic arthritis in adult patients who are intolerant to one…
06 Feb 20
Thermo Fisher’s Ion Torrent CarrierSeq ECS Kit consolidates multi-testing approach into a single workflow and facilitates global implementation
05 Feb 20
Anteros has been launched as part of the strategic partnership agreement, which was first signed in September 2019
04 Feb 20
The CATALYST clinical trial will evaluate the effectiveness of the Abbott Amplatzer Amulet compared to NOACs as an…
04 Feb 20
The transaction is expected to be closed, subject to customary closing conditions, in the third quarter of Catalent’s…
From Johnson & Johnson to GlaxoSmithKline, we take a look at the eight biggest pharma companies in the…